肾透明细胞癌肿瘤微环境预后模型免疫治疗目的 构建和验证肾透明细胞癌(kidney clear cell carcinoma, KIRC)的免疫相关预后模型在临床风险分层和预后预测的应用价值,探索肿瘤免疫微环境的特征.方法 从癌症基因组图谱(The Cancer Genome Atlas, TCGA)和国际癌症基因组联盟(International Cancer Genome Consortium, ICGC)下载...
# additional_studies tumor_tissue_site histological_type # 1 Kidney Kidney Clear Cell Renal Carcinoma # 2 Kidney Kidney Clear Cell Renal Carcinoma # 3 Kidney Kidney Clear Cell Renal Carcinoma 第三步,准备表达矩阵 在这一步中,将会把所用样本的表达矩阵汇总,随机去除重复基因名称,并以gene_name作为合并...
UCEC Uterine Corpus Endometrial Carcinoma 子宫体内膜癌 KIRC Kidney Renal Clear Cell Carcinoma 肾透明细胞癌 HNSC Head and Neck Squamous Cell Carcinoma 头颈部鳞状细胞癌 LUAD Lung Adenocarcinoma 肺腺癌 LGG Low Grade Glioma 低级别胶质瘤 THCA Thyroid Cancer 甲状腺癌 LUSC Lung Squamous Cell Carcinoma 肺鳞...
KIRC kidney clear cell carcinoma 肾透明细胞癌 KIRP kidney papillary cell carcinoma 肾乳头状细胞癌 LAML acute myeloid leukemia 急性髓细胞样白血病 LGG brain lower grade glioma 脑低级别胶质瘤 LIHC liver hepatocellular carcinoma 肝细胞肝癌 LUAD lung adenocarcinoma 肺腺癌 LUSC lung squamous cell carcinoma ...
9. KIRC(Kidney Renal Clear Cell Carcinoma):肾透明细胞癌。 肾透明细胞癌是最常见的肾癌亚型之一,起源于肾小管上皮细胞。TCGA的KIRC数据对于了解肾透明细胞癌的发展机制和潜在靶向治疗非常重要。 三、总结 TCGA项目通过深入研究和分析癌症基因组数据,为不同癌症类型的发生和发展提供了重要线索和理解。通过对TCGA中...
KIRC - Kidney renal clear cell carcinoma KIRP - Kidney renal papillary cell carcinoma LAML - Acute Myeloid Leukemia LGG - Brain Lower Grade Glioma LIHC - Liver hepatocellular carcinoma LUAD - Lung adenocarcinoma LUSC - Lung squamous cell carcinoma ...
Root(result) cl[[i]] = xmlToDataFrame(rootnode[2])}clinical = do.call(rbind,cl)clinical[1:3,1:3]# additional_studies tumor_tissue_site histological_type# 1 Kidney Kidney Clear Cell Renal Carcinoma# 2 Kidney Kidney Clear Cell Renal Carcinoma# 3 Kidney Kidney Clear Cell Renal Carcinoma...
KIRC Kidney renal clear cell carcinoma 肾透明细胞癌 KIRP Kidney renal papillary cell carcinoma 肾乳头状细胞癌 LAML Acute Myeloid Leukemia 急性髓细胞样白血病 LGG Brain Lower Grade Glioma 脑低级别胶质瘤 LIHC Liver hepatocellular carcinoma 肝细胞肝癌 LUAD Lung adenocarcinoma 肺腺癌 LUSC Lung squamous ce...
摘要:目的:通过研究泛素偶联酶E2C(ubiquitin-conjugating enzyme E2C,UBE2C)在肾透明细胞癌(kidney renal clear cell carcinoma,KIRC)组织中的表达,阐明其对KIRC早期诊断及预后的影响。方法:利用Oncomine、GEPIA数据库和人类蛋白质表达图谱(The Human Protein Atlas,HPA)分析UBE2C在KIRC组织中mRNA和蛋白质水平的变化。
kidney clear cell renal cell carcinoma (KIRC, n = 72), kidney renal papillary cell carcinoma (KIRP, n = 32), liver hepatocellular carcinoma (LIHC, n = 50), lung adenocarcinoma (LUAD, n = 57), lung squamous cell carcinoma (LUSC, n = 51), ...